# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Sep 11, 2024

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2024-09-11
- Accepted by EDGAR: Sep 11, 2024, 16:06 ET
- Period: 2024-09-05
- Accession: 0001140361-24-040837
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036124040837/ef20035750_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036124040837/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036124040837/ef20035750_8k.htm

Filed Sep 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-040837. Last ingested by Listed: Nov 10, 2026, 01:55 ET. No prices; not investment advice.
